Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer

March 3, 2025

San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a significant public health […]




UT Health San Antonio School of Dentistry researcher and her company earn Small Business Technology Transfer grant

January 30, 2025

Will partner with the school to speed oral cancer drug to market A UT Health San Antonio School of Dentistry researcher and her pioneering biotechnology company partnered with the school to earn a prestigious $400,000 Small Business Technology Transfer (STTR) grant from the National Institutes of Health to speed development of a breakthrough oral cancer drug. Cara […]





Renowned oncologist, Zheng, brings $500,000 UT System STARs award to UT Health San Antonio

January 10, 2025

  Lei Zheng, MD, PhD, executive director of the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been awarded a $500,000 Translational Science and Technology Acquisition and Retention (STARs) award from The University of Texas System to elevate his research into monitoring pancreatic tumor […]

Image of Star trophy